KK4277
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KK4277, covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus [Phase 1]